A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects

Authors

Kaushik Ghosal, ReXceptor LLC
Michael Haag, ReXceptor LLC
Philip B. Verghese, C2N Diagnostics LLC
Tim West, C2N Diagnostics LLC
Tim Veenstra, C2N Diagnostics LLC
Joel B. Braunstein, C2N Diagnostics LLC
Randall J. Bateman, Washington University School of Medicine in St. Louis
David M. Holtzman, Washington University School of Medicine in St. Louis
Gary E. Landreth, Case Western Reserve University

Journal

Alzheimer's & Dementia: Translational Research & Clinical Interventions

Publication Date

2016

Volume

2

Issue

2

Inclusive Pages

110-120

Document Type

Open Access Publication

DOI

10.1016/j.trci.2016.06.001

Rights and Permissions

K Ghosal, et al (2016) A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2(2): 110-120. http://dx.doi.org/10.1016/j.trci.2016.06.001

Recommended Citation

Ghosal, Kaushik; Haag, Michael; Verghese, Philip B.; West, Tim; Veenstra, Tim; Braunstein, Joel B.; Bateman, Randall J.; Holtzman, David M.; and Landreth, Gary E., "A randomized controlled study to evaluate the effect of bexarotene on amyloid-β and apolipoprotein E metabolism in healthy subjects." Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2, 2. 110-120. (2016).
https://digitalcommons.wustl.edu/open_access_pubs/5187